West Pharma (WST) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $329.71 --0%
Revenue Growth %: +9.5%
Financial Fact:
Net sales: 376.7M
Today's EPS Names:
JFIN, KEQU, LASE, More
Revenue Growth %: +9.5%
Financial Fact:
Net sales: 376.7M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q4 EPS of $0.54, $0.02 worse than the analyst estimate of $0.56. Revenue for the quarter came in at $382.3 million versus the consensus estimate of $387.31 million.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Keurig Dr Pepper coffee chief to depart ahead of planned split
- NVE Corporation names new CEO and expands board to seven members
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
